secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2024-05-22T23:59:59+00:00
Accession:  0000950170-24-063494
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Heart Test Labs obtains temporary stay of Nasdaq delisting; hearing set for June 27
--------------------------------------------------------------------------------

- Nasdaq delisting action stayed pending oral hearing on June 27, 2024.
- Company implemented 1-for-100 reverse stock split on May 17, 2024.
- Previously, stock closed at $0.10 or less for 10 consecutive days triggering Low Priced Stocks Rule.
- Company intends to argue it has regained compliance with Minimum Bid Price and Low Priced Stocks Rules.
- No assurance of successful appeal; shares continue trading under HSCS and HSCSW pending outcome.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024063494/0000950170-24-063494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017024063494/hscs-20240516.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-063494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer